Designing food structure and composition to enhance nutraceutical bioactivity to support cancer inhibition

Seminars in Cancer Biology

Volumn 46, Issue , 2017, Pages 215-226

  McClements, David Julian ^a   Xiao, Hang ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Bioavailability; Cancer; Delivery systems; Excipients; Nutraceuticals

Indexed keywords

CURCUMIN; EXCIPIENT; FLAVONOID; LIPOSOME; NUTRACEUTICAL; POLYPHENOL; QUERCETIN; RESVERATROL; SOLID LIPID NANOPARTICLE; SULFORAPHANE; TANGERETIN; ANTINEOPLASTIC AGENT;

BIOLOGICAL ACTIVITY; CANCER INHIBITION; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DETERMINATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG TRANSFORMATION; EMULSION; HUMAN; HYDROGEL; MICROEMULSION; NONHUMAN; PARTICLE SIZE; REVIEW; BIOAVAILABILITY; DIET THERAPY; DIETARY SUPPLEMENT; NEOPLASM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; DIETARY SUPPLEMENTS; HUMANS; NEOPLASMS;

EID: 85020407041     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2017.06.003     Document Type: Review

References (129)

1. Gupta, R.C., Nutraceuticals: Efficacy, Safety and Toxicity. 2016, Academic Press, London, U.K.
2. Wildman, R.E.C., Kelley, M., Nutraceuticals and functional foods. Wildman, R.E.C., (eds.) Handbook of Nutraceuticals and Functional Foods, 2nd ed., 2007, CRC Press, Boco Raton, FL, 1–22.
3. Bagchi, D., Preuss, H.G., Sarwoop, A., Nutraceuticals and Functional Foods in Human Health and Disease Prevention. 2015, CRC Press, Boca Raton, FL.
4. McClements, D.J., Nanoparticle- and Microparticle-based Delivery Systems. 2015, CRC Press, Boca Raton, FL.
5. Gleeson, J.P., Ryan, S.M., Brayden, D.J., Oral delivery strategies for nutraceuticals: delivery vehicles and absorption enhancers. Trends Food Sci. Technol. 53 (2016), 90–101.
6. McClements, D.J., Enhancing nutraceutical bioavailability through food matrix design. Curr. Opin. Food Sci. 4 (2015), 1–6.
7. McClements, D.J., Li, F., Xiao, H., The nutraceutical bioavailability classification scheme: classifying nutraceuticals according to factors limiting their oral bioavailability. Ann. Rev. Food Sci. Technol. 6 (2015), 299–327.
8. Cai, H., Scott, E., Kholghi, A., Andreadi, C., Rufini, A., Karmokar, A., Britton, R.G., Horner-Glister, E., Greaves, P., Jawad, D., James, M., Howells, L., Ognibene, T., Malfatti, M., Goldring, C., Kitteringham, N., Walsh, J., Viskaduraki, M., West, K., Miller, A., Hemingway, D., Steward, W.P., Gescher, A.J., Brown, K., Cancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci. Transl. Med., 7(298), 2015.
9. Arora, D., Jaglan, S., Nanocarriers based delivery of nutraceuticals for cancer prevention and treatment: a review of recent research developments. Trends Food Sci. Technol. 54 (2016), 114–126.
10. McClements, D.J., Decker, E.A., Weiss, J., Emulsion-based delivery systems for lipophilioc bioactive components. J. Food Sci. 72:8 (2007), R109–R124.
11. Sagalowicz, L., Leser, M.E., Delivery systems for liquid food products. Curr. Opin. Colloid Interface Sci. 15:1–2 (2010), 61–72.
12. Salvia-Trujillo, L., Qian, C., Martin-Belloso, O., McClements, D.J., Influence of particle size on lipid digestion and beta-carotene bioaccessibility in emulsions and nanoemulsions. Food Chem. 141:2 (2013), 1472–1480.
13. McClements, D.J., Xiao, H., Excipient foods: designing food matrices that improve the oral bioavailability of pharmaceuticals and nutraceuticals. Food Function 5:7 (2014), 1320–1333.
14. Zhang, R.J., Zhang, Z.P., Zou, L.Q., Xiao, H., Zhang, G.D., Decker, E.A., McClements, D.J., Impact of lipid content on the ability of excipient emulsions to increase carotenoid bioaccessibility from natural sources (raw and cooked carrots). Food Biophys. 11:1 (2016), 71–80.
15. Arvanitoyannis, I.S., van Houwelingen-Koukaliaroglou, M., Functional foods: a survey of health claims, pros and cons, and current legislation. Crit. Rev. Food Sci. Nutr. 45:5 (2005), 385–404.
16. Ullah, M.F., Khan, M.W., Food as medicine: potential therapeutic tendencies of plant derived polyphenolic compounds. Asian Pac. J. Cancer Prev. 9:2 (2008), 187–195.
17. Kotecha, R., Takami, A., Espinoza, J.L., Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget 7:32 (2016), 52517–52529.
18. Pan, M.H., Ho, C.T., Chemopreventive effects of natural dietary compounds on cancer development. Chem. Soc. Rev. 37:11 (2008), 2558–2574.
19. Joe, B., Vijaykumar, M., Lokesh, B.R., Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr. 44:2 (2004), 97–111.
20. Perrone, D., Ardito, F., Giannatempo, G., Dioguardi, M., Troiano, G., Lo Russo, L., De Lillo, A., Laino, L., Lo Muzio, L., Biological and therapeutic activities, and anticancer properties of curcumin (Review). Exp. Therap. Med. 10:5 (2015), 1615–1623.
21. Bar-Sela, G., Epelbaum, R., Schaffer, M., Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr. Med. Chem. 17:3 (2010), 190–197.
22. Carroll, R.E., Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia (vol. 4, pg 354, 2011). Cancer Prev. Res., 5(12), 2012 1407–1407.
23. Ting, Y.W., Jiang, Y., Ho, C.T., Huang, Q.R., Common delivery systems for enhancing in vivo bioavailability and biological efficacy of nutraceuticals. J. Funct. Foods 7 (2014), 112–128.
24. Ghosh, D., Choudhury, S.T., Ghosh, S., Mandal, A.K., Sarkar, S., Ghosh, A., Saha, K.D., Das, N., Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat. Chem. Biol. Interact. 195:3 (2012), 206–214.
25. Schiborr, C., Kocher, A., Behnam, D., Jandasek, J., Toelstede, S., Frank, J., The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol. Nutr. Food Res. 58:3 (2014), 516–527.
26. Bhat, K.P.L., Kosmeder, J.W., Pezzuto, J.M., Biological effects of resveratrol. Antioxid. Redox Signal. 3:6 (2001), 1041–1064.
27. Kundu, J.K., Surh, Y.J., Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 269:2 (2008), 243–261.
28. Smoliga, J.M., Baur, J.A., Hausenblas, H.A., Resveratrol and health – a comprehensive review of human clinical trials. Mol. Nutr. Food Res. 55:8 (2011), 1129–1141.
29. Shukla, Y., Singh, R., Resveratrol and cellular mechanisms of cancer prevention. Ann. N. Y. Acad. Sci. 1215 (2011), 1–8.
30. Nguyen, A.V., Martinez, M., Stamos, M.J., Moyer, M.P., Planutis, K., Hope, C., Holcombe, R.F., Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manage. Res. 1 (2009), 25–37.
31. Zhu, W.Z., Qin, W.Y., Zhang, K., Rottinghaus, G.E., Chen, Y.C., Kliethermes, B., Sauter, E.R., Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for Breast cancer. Nutr. Cancer 64:3 (2012), 393–400.
32. Narayanan, N.K., Nargi, D., Randolph, C., Narayanan, B.A., Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int. J. Cancer 125:1 (2009), 1–8.
33. Dinkova-Kostova, A.T., Kostov, R.V., Glucosinolates and isothiocyanates in health and disease. Trends Mol. Med. 18:6 (2012), 337–347.
34. Houghton, C.A., Fassett, R.G., Coombes, J.S., Sulforaphane: translational research from laboratory bench to clinic. Nutr. Rev. 71:11 (2013), 709–726.
35. Clarke, J.D., Dashwood, R.H., Ho, E., Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 269:2 (2008), 291–304.
36. Juge, N., Mithen, R.F., Traka, M., Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell. Mol. Life Sci. 64:9 (2007), 1105–1127.
37. Alumkal, J.J., Slottke, R., Schwartzman, J., Cherala, G., Munar, M., Graff, J.N., Beer, T.M., Ryan, C.W., Koop, D.R., Gibbs, A., Gao, L.N., Flamiatos, J.F., Tucker, E., Kleinschmidt, R., Mori, M., A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer. Invest. New Drugs 33:2 (2015), 480–489.
38. Yanaka, A., Fahey, J.W., Fukumoto, A., Nakayama, M., Inoue, S., Zhang, S.H., Tauchi, M., Suzuki, H., Hyodo, I., Yamamoto, M., Dietary sulforaphane-Rich broccoli sprouts reduce colonization and attenuate gastritis in helicobacter pylori-infected mice and humans. Cancer Prev. Res. 2:4 (2009), 353–360.
39. Do, D.P., Pai, S.B., Rizvi, S.A.A., D'Souza, M.J., Development of sulforaphane-encapsulated microspheres for cancer epigenetic therapy. Int. J. Pharm. 386:1–2 (2010), 114–121.
40. Cabrera, C., Artacho, R., Gimenez, R., Beneficial effects of green tea – a review. J. Am. Coll. Nutr. 25:2 (2006), 79–99.
41. Crozier, A., Jaganath, I.B., Clifford, M.N., Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep. 26:8 (2009), 1001–1043.
42. Nijveldt, R.J., van Nood, E., van Hoorn, D.E.C., Boelens, P.G., van Norren, K., van Leeuwen, P.A.M., Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74:4 (2001), 418–425.
43. Yang, C.S., Li, G., Yang, Z., Guan, F., Chen, A., Ju, J., Cancer prevention by tocopherols and tea polyphenols. Cancer Lett. 334:1 (2013), 79–85.
44. Gee, J., Saltzstein, D., Kim, K., Kolesar, J., Huang, W., Havighurst, T., Wollmer, B., Stublaski, J., Downs, T., Mukhtar, H., House, M., Parnes, H., Bailey, H., A phase ii randomized, presurgical placebo-controlled trial of polyphenon e in bladder cancer patients to evaluate bladder tissue levels of egcg and biomarkers of growth and apoptosis. J. Urol., 193(4), 2015 E293–E293.
45. Sun, C.L., Yuan, J.M., Koh, W.P., Yu, M.C., Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 27:7 (2006), 1310–1315.
46. Manach, C., Williamson, G., Morand, C., Scalbert, A., Remesy, C., Bioavailability and bioefficacy of polyphenols in humans. I: review of 97 bioavailability studies. Am. J. Clin. Nutr. 81:1 (2005), 230S–242S.
47. Tapas, A.R., Sakarkar, D.M., Kakde, R.B., Flavonoids as nutraceuticals: a review. Trop. J. Pharm. Res. 7:3 (2008), 1089–1099.
48. Weng, C.J., Yen, G.C., Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev. 31:1–2 (2012), 323–351.
49. Batra, P., Sharma, A.K., Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech 3:6 (2013), 439–459.
50. Chirumbolo, S., Quercetin in cancer prevention and therapy. Integr. Cancer Ther. 12:2 (2013), 97–102.
51. Yang, F.Y., Song, L.M., Wang, H.P., Wang, J., Xu, Z.Q., Xing, N.Z., Quercetin in prostate cancer: chemotherapeutic and chemopreventive effects, mechanisms and clinical application potential (review). Oncol. Rep. 33:6 (2015), 2659–2668.
52. Lu, W., Kelly, A.L., Miao, S., Emulsion-based encapsulation and delivery systems for polyphenols. Trends Food Sci. Technol. 47 (2016), 1–9.
53. Guazelli, C.F.S., Fattori, V., Colombo, B.B., Georgetti, S.R., Vicentini, F.T.M.C., Casagrande, R., Baracat, M.M., Verri, W.A., Quercetin-loaded microcapsules ameliorate experimental colitis in mice by anti-inflammatory and antioxidant mechanisms. J. Nat. Prod. 76:2 (2013), 200–208.
54. Ting, Y.W., Chiou, Y.S., Pan, M.H., Ho, C.T., Huang, Q.R., In vitro and in vivo anti-cancer activity of tangeretin against colorectal cancer was enhanced by emulsion-based delivery system. J. Funct. Foods 15 (2015), 264–273.
55. Arnott, J.A., Planey, S.L., The influence of lipophilicity in drug discovery and design. Expert Opin. Drug Discovery 7:10 (2012), 863–875.
56. McClements, D.J., Utilizing food effects to overcome challenges in delivery of lipophilic bioactives: structural design of medical and functional foods. Expert Opin. Drug Deliv. 10:12 (2013), 1621–1632.
57. Yao, M.F., McClements, D.J., Xiao, H., Improving oral bioavailability of nutraceuticals by engineered nanoparticle-based delivery systems. Curr. Opin. Food Sci. 2 (2015), 14–19.
58. McClements, D.J., Nanoparticle- and Microparticle-based Delivery Systems: Encapsulation, Protection and Release of Active Components. 2015, CRC Press, Boca Raton, FL.
59. Jeffery, J., Holzenburg, A., King, S., Physical barriers to carotenoid bioaccessibility. Ultrastructure survey of chromoplast and cell wall morphology in nine carotenoid-containing fruits and vegetables. J. Sci. Food Agric. 92:13 (2012), 2594–2602.
60. Parada, J., Aguilera, J.M., Food microstructure affects the bioavailability of several nutrients. J. Food Sci. 72:2 (2007), R21–R32.
61. Saini, R.K., Nile, S.H., Park, S.W., Carotenoids from fruits and vegetables: chemistry, analysis, occurrence: bioavailability and biological activities. Food Res. Int. 76 (2015), 735–750.
62. Rein, M.J., Renouf, M., Cruz-Hernandez, C., Actis-Goretta, L., Thakkar, S.K., Pinto, M.D., Bioavailability of bioactive food compounds: a challenging journey to bioefficacy. Br. J. Clin. Pharmacol. 75:3 (2013), 588–602.
63. Scaldaferri, F., Pizzoferrato, M., Gerardi, V., Lopetuso, L., Gasbarrini, A., The gut barrier new acquisitions and therapeutic approaches. J. Clin. Gastroenterol. 46:9 (2012), S12–S17.
64. Cone, R.A., Barrier properties of mucus. Adv. Drug Deliv. Rev. 61:2 (2009), 75–85.
65. Dahan, A., Miller, J.M., The solubility-Permeability interplay and its implications in formulation design and development for poorly soluble drugs. Aaps J. 14:2 (2012), 244–251.
66. Fasinu, P., Pillay, V., Ndesendo, V.M.K., du Toit, L.C., Choonara, Y.E., Diverse approaches for the enhancement of oral drug bioavailability. Biopharm. Drug Dispos. 32:4 (2011), 185–209.
67. Dudhatra, G.B., Mody, S.K., Awale, M.M., Patel, H.B., Modi, C.M., Kumar, A., Kamani, D.R., Chauhan, B.N., A comprehensive review on pharmacotherapeutics of herbal bioenhancers. Sci. World J., 2012.
68. Lo, C.M., Tso, P., Physicochemical basis of the digestion and absorption of triacylglycerol. Des. Funct. Foods, 2009, 94–125.
69. Tso, P., Nauli, A., Lo, C.M., Enterocyte fatty acid uptake and intestinal fatty acid-binding protein. Biochem. Soc. Trans. 32 (2004), 75–78.
70. Kosinska, A., Andlauer, W., Modulation of tight junction integrity by food components. Food Res. Int. 54:1 (2013), 951–960.
71. Seki, T., Harada, S., Hosoya, O., Morimoto, K., Juni, K., Evaluation of the establishment of a tight junction in Caco-2 cell monolayers using a pore permeation model involving two different sizes. Biol. Pharm. Bull. 31:1 (2008), 163–166.
72. Tsutsumi, K., Li, S.K., Hymas, R.V., Teng, C.L., Tillman, L.G., Hardee, G.E., Higuchi, W.I., Ho, N.F.H., Systematic studies on the paracellular permeation of model permeants and Oligonucleotides in the rat small intestine with chenodeoxycholate as enhancer. J. Pharm. Sci. 97:1 (2008), 350–367.
73. Lerner, A., Matthias, T., Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun. Rev. 14:6 (2015), 479–489.
74. Rosenthal, R., Heydt, M.S., Amasheh, M., Stein, C., From, M., Amasheh, S., Analysis of absorption enhancers in epithelial cell models. Fromm, M., Schulzke, J.D., (eds.) Barriers and Channels Formed by Tight Junction Proteins II, vol. 1258, 2012, Annals of the New York Academy of Sciences, New York, NY, 86–92.
75. Shimizu, M., Interaction between food substances and the intestinal epithelium. Biosci. Biotechnol. Biochem. 74:2 (2010), 232–241.
76. Misaka, S., Muller, F., Fromm, M.F., Clinical relevance of drug efflux pumps in the gut. Curr. Opin. Pharmacol. 13:6 (2013), 847–852.
77. Actis-Goretta, L., Leveques, A., Rein, M., Teml, A., Schafer, C., Hofmann, U., Li, H.Q., Schwab, M., Eichelbaum, M., Williamson, G., Intestinal absorption, metabolism, and excretion of (−)-epicatechin in healthy humans assessed by using an intestinal perfusion technique. Am. J. Clin. Nutr. 98:4 (2013), 924–933.
78. Carail, M., Goupy, P., Reynaud, E., Dangles, O., Caris-Veyrat, C., Oxidative cleavage products of lycopene: production and reactivity in a biomimetic experimental model of oxidative stress. Winterhalter, P., Ebeler, S.E., (eds.) Carotenoid Cleavage Products, vol. 1134, 2013, Amer Chemical Soc., Washington, 191–205.
79. Kenmogne-Domguia, H.B., Moisan, S., Viau, M., Genot, C., Meynier, A., The initial characteristics of marine oil emulsions and the composition of the media inflect lipid oxidation during in vitro gastrointestinal digestion. Food Chem. 152 (2014), 146–154.
80. Ferruzzi, M.G., Lumpkin, J.L., Schwartz, S.J., Failla, M., Digestive stability, micellarization, and uptake of beta-carotene isomers by Caco-2 human intestinal cells. J. Agric. Food Chem. 54:7 (2006), 2780–2785.
81. Salem, M., Rohani, S., Gillies, E.R., Curcumin, a promising anti-cancer therapeutic: a review of its chemical properties, bioactivity and approaches to cancer cell delivery. RSC Adv. 4:21 (2014), 10815–10829.
82. Planas, J.M., Alfaras, I., Colom, H., Juan, M.E., The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters. Arch. Biochem. Biophys. 527:2 (2012), 67–73.
83. Petri, N., Tannergren, C., Holst, B., Mellon, F.A., Bao, Y.P., Plumb, G.W., Bacon, J., O'Leary, K.A., Kroon, P.A., Knutson, L., Forsell, P., Eriksson, T., Lennernas, H., Williamson, G., Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab. Dispos. 31:6 (2003), 805–813.
84. Sun, Y., Wu, X., Cai, X.K., Song, M.Y., Zheng, J.K., Pan, C., Qiu, P.J., Zhang, L.J., Zhou, S.D., Tang, Z.H., Xiao, H., Identification of pinostilbene as a major colonic metabolite of pterostilbene and its inhibitory effects on colon cancer cells. Mol. Nutr. Food Res. 60:9 (2016), 1924–1932.
85. Wu, X., Song, M., Wang, M., Zheng, J., Gao, Z., Xu, F., Zhang, G., Xiao, H., Chemopreventive effects of nobiletin and its colonic metabolites on colon carcinogenesis. Mol. Nutr. Food Res. 59:12 (2015), 2383–2394.
86. Zheng, J., Song, M., Dong, P., Qiu, P., Guo, S., Zhong, Z., Li, S., Ho, C.T., Xiao, H., Identification of novel bioactive metabolites of 5-demethylnobiletin in mice. Mol. Nutr. Food Res. 57:11 (2013), 1999–2007.
87. Dahan, A., Miller, J.M., Amidon, G.L., Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs. Aaps J. 11:4 (2009), 740–746.
88. Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., Onoue, S., Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int. J. Pharm. 420:1 (2011), 1–10.
89. Lennernas, H., Abrahamsson, B., The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension. J. Pharm. Pharmacol. 57:3 (2005), 273–285.
90. McClements, D.J., Li, F., Xiao, H., The nutraceutical bioavailability classification scheme: classifying nutraceuticals according to factors limiting their oral bioavailability. Ann. Rev. Food Sci. Technol., 6, 2015.
91. Flanagan, J., Singh, H., Microemulsions: a potential delivery system for bioactives in food. Crit. Rev. Food Sci. Nutr. 46:3 (2006), 221–237.
92. Spernath, A., Aserin, A., Microemulsions as carriers for drugs and nutraceuticals. Adv. Colloid Interface Sci. 128 (2006), 47–64.
93. McClements, D.J., Advances in fabrication of emulsions with enhanced functionality using structural design principles. Curr. Opin. Colloid Interface Sci. 17:5 (2012), 235–245.
94. McClements, D.J., Rao, J., Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity. Crit. Rev. Food Sci. Nutr. 51:4 (2011), 285–330.
95. Guri, A., Guelseren, I., Corredig, M., Utilization of solid lipid nanoparticles for enhanced delivery of curcumin in cocultures of HT29-MTX and Caco-2 cells. Food Funct. 4:9 (2013), 1410–1419.
96. Mehnert, W., Mader, K., Solid lipid nanoparticles: production: characterization and applications. Adv. Drug Deliv. Rev. 64 (2012), 83–101.
97. Chen, L.Y., Remondetto, G.E., Subirade, M., Food protein-based materials as nutraceutical delivery systems. Trends iFood Sci. Technol. 17:5 (2006), 272–283.
98. Joye, I.J., McClements, D.J., Biopolymer-based nanoparticles and microparticles: fabrication, characterization, and application. Curr. Opin. Colloid Interface Sci. 19:5 (2014), 417–427.
99. Shewan, H.M., Stokes, J.R., Review of techniques to manufacture micro-hydrogel particles for the food industry and their applications. J. Food Eng. 119:4 (2013), 781–792.
100. Zhang, R.J., Zhang, Z.P., Zou, L.Q., Xiao, H., Zhang, G.D., Decker, E.A., McClements, D.J., Enhancing nutraceutical bioavailability from raw and cooked vegetables using excipient emulsions: influence of lipid type on carotenoid bioaccessibility from carrots. J. Agric. Food Chem. 63:48 (2015), 10508–10517.
101. Zhang, Z.P., Zhang, R.J., Chen, L., Tong, Q.Y., McClements, D.J., Designing hydrogel particles for controlled or targeted release of lipophilic bioactive agents in the gastrointestinal tract. Eur. Polym. J. 72 (2015), 698–716.
102. Desai, K.G.H., Park, H.J., Recent developments in microencapsulation of food ingredients. Drying Technol. 23:7 (2005), 1361–1394.
103. Fathi, M., Mozafari, M.R., Mohebbi, M., Nanoencapsulation of food ingredients using lipid based delivery systems. Trends Food Sci. Technol. 23:1 (2012), 13–27.
104. Mozafari, M.R., Johnson, C., Hatziantoniou, S., Demetzos, C., Nanoliposomes and their applications in food nanotechnology. J. Liposome Res. 18:4 (2008), 309–327.
105. Zou, L.Q., Zheng, B.J., Liu, W., Liu, C.M., Xiao, H., McClements, D.J., Enhancing nutraceutical bioavailability using excipient emulsions: influence of lipid droplet size on solubility and bioaccessibility of powdered curcumin. J. Funct. Foods 15 (2015), 72–83.
106. Donsi, F., Sessa, M., Mediouni, H., Mgaidi, A., Ferrari, G., Encapsulation of bioactive compounds in nanoemulsion-based delivery systems. Saravacos, G., Taoukis, P., Krokida, M., Karathanos, V., Lazarides, H., Stoforos, N., Tzia, C., Yanniotis, S., (eds.) 11th International Congress on Engineering and Food, vol. 1, 2011, 1666–1671.
107. Braithwaite, M.C., Tyagi, C., Tomar, L.K., Kumar, P., Choonara, Y.E., Pillay, V., Nutraceutical-based therapeutics and formulation strategies augmenting their efficiency to complement modern medicine: an overview. J. Funct. Foods 6 (2014), 82–99.
108. Lu, N.T., Crespi, C.M., Liu, N.M., Vu, J.Q., Ahmadieh, Y., Wu, S., Lin, S., McClune, A., Durazo, F., Saab, S., Han, S., Neiman, D.C., Beaven, S., French, S.W., A phase I dose escalation study demonstrates quercetin safety and explores potential for bioflavonoid antivirals in patients with chronic hepatitis C. Phytother. Res. 30:1 (2016), 160–168.
109. Yallapu, M.M., Nagesh, P.K.B., Jaggi, M., Chauhan, S.C., Therapeutic applications of curcumin nanoformulations. Aaps J. 17:6 (2015), 1341–1356.
110. Davidov-Pardo, G., McClements, D.J., Nutraceutical delivery systems: resveratrol encapsulation in grape seed oil nanoemulsions formed by spontaneous emulsification. Food Chem. 167 (2015), 205–212.
111. Qian, C., Decker, E.A., Xiao, H., McClements, D.J., Inhibition of beta-carotene degradation in oil-in-water nanoemulsions: influence of oil-soluble and water-soluble antioxidants. Food Chem. 135:3 (2012), 1036–1043.
112. Tamjidi, F., Shahedi, M., Varshosaz, J., Nasirpour, A., EDTA and alpha-tocopherol improve the chemical stability of astaxanthin loaded into nanostructured lipid carriers. Eur. J. Lipid Sci. Technol. 116:8 (2014), 968–977.
113. Ozturk, B., Argin, S., Ozilgen, M., McClements, D.J., Nanoemulsion delivery systems for oil-soluble vitamins: influence of carrier oil type on lipid digestion and vitamin D-3 bioaccessibility. Food Chem. 187 (2015), 499–506.
114. Salvia-Trujillo, L., Qian, C., Martin-Belloso, O., McClements, D.J., Modulating beta-carotene bioaccessibility by controlling oil composition and concentration in edible nanoemulsions. Food Chem. 139:1–4 (2013), 878–884.
115. Salvia-Trujillo, L., Sun, Q., Urn, B.H., Park, Y., McClements, D.J., In vitro and in vivo study of fucoxanthin bioavailability from nanoemulsion-based delivery systems: impact of lipid carrier type. J. Funct. Foods 17 (2015), 293–304.
116. Yao, M.F., Xiao, H., McClements, D.J., Delivery of lipophilic bioactives: assembly, disassembly, and reassembly of lipid nanoparticles. Doyle, M.P., Klaenhammer, T.R., (eds.) Ann. Rev. Food Sci. Technol., 5, 2014, 53081.
117. de Sousa, I.P., Cattoz, B., Wilcox, M.D., Griffiths, P.C., Dalgliesh, R., Rogers, S., Bernkop-Schnurch, A., Nanoparticles decorated with proteolytic enzymes: a promising strategy to overcome the mucus barrier. Eur. J. Pharm. Biopharm. 97 (2015), 257–264.
118. McCartney, F., Gleeson, J.P., Brayden, D.J., Safety concerns over the use of intestinal permeation enhancers: a mini-review. Tissue Barriers, 4(2), 2016.
119. McClements, D.J., Zou, L.Q., Zhang, R.J., Salvia-Trujillo, L., Kumosani, T., Xiao, H., Enhancing nutraceutical performance using excipient foods: designing food structures and compositions to increase bioavailability. Compr. Rev. Food Sci. Food Saf. 14:6 (2015), 824–847.
120. Salvia-Trujillo, L., McClements, D.J., Improvement of beta-carotene bioaccessibility from dietary supplements using excipient nanoemulsions. J. Agric. Food Chem. 64:22 (2016), 4639–4647.
121. Liu, X., Bi, J.F., Xiao, H., McClements, D.J., Enhancement of nutraceutical bioavailability using excipient nanoemulsions: role of lipid digestion products on bioaccessibility of carotenoids and phenolics from mangoes. J. Food Sci. 81:3 (2016), N754–N761.
122. Liu, X., Bi, J.F., Xiao, H., McClements, D.J., Increasing carotenoid bioaccessibility from yellow peppers using excipient emulsions: impact of lipid type and thermal processing. J. Agric. Food Chem. 63:38 (2015), 8534–8543.
123. Salvia-Trujillo, L., McClements, D.J., Enhancement of lycopene bioaccessibility from tomato juice using excipient emulsions: influence of lipid droplet size. Food Chem. 210 (2016), 295–304.
124. Cho, H.T., Salvia-Trujillo, L., Kim, J., Park, Y., Xiao, H., McClements, D., Droplet size and composition of nutraceutical nanoemulsions influences bioavailability of long chain fatty acids and Coenzyme Q10. Food Chem. 156 (2014), 117–122.
125. Zhang, R.J., Zhang, Z.P., Zou, L.Q., Xiao, H., Zhang, G.D., Decker, E.A., McClements, D.J., Enhancement of carotenoid bioaccessibility from carrots using excipient emulsions: influence of particle size of digestible lipid droplets. Food Funct. 7:1 (2016), 93–103.
126. Zou, L.Q., Liu, W., Liu, W.L., Liang, R.H., Li, T., Liu, C.M., Cao, Y.L., Niu, J., Liu, Z., Characterization and bioavailability of tea polyphenol nanoliposome prepared by combining an ethanol injection method with dynamic high-pressure microfluidization. J. Agric. Food Chem. 62:4 (2014), 934–941.
127. Zou, L.Q., Liu, W., Liu, C.M., Xiao, H., McClements, D.J., Designing excipient emulsions to increase nutraceutical bioavailability: emulsifier type influences curcumin stability and bioaccessibility by altering gastrointestinal fate. Food Funct. 6:8 (2015), 2475–2486.
128. Baker, M., Deceptive curcumin offers cautionary tale for chemists. Nature 541 (2017), 144–145.
129. Nelson, K.M., Dahlin, J.L., Bisson, J., Graham, J., Pauli, G.F., Walters, M.A., The essential medicinal chemistry of curcumin. J. Med. Chem. 60:5 (2017), 1620–1637.